CoChat

Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov

Open access
Bourgeois, Florence T., Murthy, Srinivas, Mandl, Kenneth D. · 2010 · Annals of Internal Medicine

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Clinical trial registries are in widespread use to promote transparency around trials and their results. OBJECTIVE: To describe characteristics of drug trials listed in ClinicalTrials.gov and examine whether the funding source of these trials is associated with favorable published outcomes. DESIGN: An observational study of safety and efficacy trials for anticholesteremics, antidepressants, antipsychotics, proton-pump inhibitors, and vasodilators conducted between 2000 and 2006. SETTING: ClinicalTrials.gov, a Web-based registry of clinical trials launched in 1999. MEASUREMENTS: Publications resulting from the trials for the 5 drug categories of interest were identified, and data were abstracted on the trial record and publication, including timing of registration, elements of the study design, funding source, publication date, and study outcomes. Assessments were based on the primary funding categories of industry, government agencies, and nonprofit or nonfederal organizations. RESULTS: Among 546 drug trials, 346 (63%) were primarily funded by industry, 74 (14%) by government sources, and 126 (23%) by nonprofit or nonfederal organizations. Trials funded by industry were more likely to be phase 3 or 4 trials (88.7%; P < 0.001 across groups), to use an active comparator in controlled trials (36.8%; P = 0.010 across groups), to be multicenter (89.0%; P < 0.001 across groups), and to enroll more participants (median sample size, 306 participants; P < 0.001 across groups). Overall, 362 (66.3%) trials had published results. Industry-funded trials reported positive outcomes in 85.4% of publications, compared with 50.0% for government-funded trials and 71.9% for nonprofit or nonfederal organization-funded trials (P < 0.001). Trials funded by nonprofit or nonfederal sources with industry contributions were also more likely to report positive outcomes than those without industry funding (85.0% vs. 61.2%; P = 0.013). Rates of trial publication within 24 months of study completion ranged from 32.4% among industry-funded trials to 56.2% among nonprofit or nonfederal organization-funded trials without industry contributions (P = 0.005 across groups). LIMITATIONS: The publication status of a trial could not always be confirmed, which could result in misclassification. Additional information on study protocols and comprehensive trial results were not available to further explore underlying factors for the association between funding source and outcome reporting. CONCLUSION: In this sample of registered drug trials, those funded by industry were less likely to be published within 2 years of study completion and were more likely to report positive outcomes than were trials funded by other sources. PRIMARY FUNDING SOURCE: National Library of Medicine and National Institute of Child Health and Human Development, National Institutes of Health.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-153-3-201008030-00006

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Bhandari M, 2004, CMAJ, 170, 477

Cited by

See all 332

Metadata

Authors
Bourgeois, F. T., Murthy, S., & Mandl, K. D.
Affiliations
Boston Children's Hospital (US)
Corresponding author
Bourgeois, Florence T.
Venue
Annals of Internal Medicine
Published
2010-08-03
Volume
153
Issue
3
Pages
158-166
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1967992635
Cited by
332
References
43
Citations by year
2026: 3 · 2025: 3 · 2024: 6 · 2023: 13 · 2022: 18 · 2021: 35 · 2020: 12 · 2019: 16 · 2018: 20 · 2017: 19 · 2016: 24 · 2015: 28 · 2014: 32 · 2013: 36 · 2012: 32
FWCI
32.83
Type
journal article
Language
en
Open access
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • U.S. National Library of Medicine (G08LM009778)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD040128)
Topics
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords
ClinicalTrials.gov, clinical trial registries, outcome reporting, publication bias, industry funding, trial funding, drug trials, antidepressants, antipsychotic drugs, proton pump inhibitors, vasodilators, clinical trial transparency, sample size, trial phase
MeSH terms
Clinical Trials as Topic, Drug Evaluation, Financing, Government, Financing, Organized, National Library of Medicine (U.S.), Periodicals as Topic, Registries, Research Support as Topic, United States, Publication Bias, Internet, Editorial Policies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov. https://app.cochat.ai/papers/10.7326/0003-4819-153-3-201008030-00006
The paper
Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010). Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-153-3-201008030-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.